Menorrhagia at the time of menarche is relatively common and historically attributed
primarily to immaturity of the pituitary–ovarian–uterine axis. Intuitively, a proportion of these …

Background Mefenamic acid is a non‐steroidal anti‐inflammatory drug (NSAID). It is most
often used for treating pain of dysmenorrhoea in the short term (seven days or less), as well …

Objective. The purpose of this study is to identify menstruation characteristics of the women
and the effects of menorrhagia on women's quality of life. Methods. The study was designed …

Background Heavy menstrual bleeding without an organic lesion is mainly due to an
imbalance of the various hormones which have a regulatory effect on the menstrual cycle …

Objectives To compare the diagnostic accuracy of brush endometrial sampling with
conventional dilatation and curettage in women with abnormal uterine bleeding. Patients …

Background: Genome-wide-association studies have identified the TMPRSS6 polymorphism
rs855791 has the strongest association with red blood cell indices or iron parameters in …

Results Infarct-type necrosis was observed in the leiomyomas of 38 patients, 22 of whom
had tranexamic acid (15%) whereas the remaining 16 had no drug exposure (4.7%)(odds …

Objective The purpose of this study was to examine the frequency and clustering of somatic
symptoms as reported by women aged 45 to 55 years in four countries, to compare women's …

Aim: To evaluate the efficacy and safety of oral, modified-release tranexamic acid in women
with heavy menstrual bleeding and fibroids. Materials & methods: This was a pooled …

Background: Menorrhagia, by definition, is heavy cyclical blood loss in excess of 80
ml/month of menstrual period lasting longer than 7 days. There are many possible causes of …